- Home
- ZOOZ vs UNCY Comparison
ZOOZ vs UNCY Comparison
Compare ZOOZ & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- UNCY
- Stock Information
- Founded
- ZOOZ 2013
- UNCY 2016
- Country
- ZOOZ Israel
- UNCY United States
- Employees
- ZOOZ N/A
- UNCY N/A
- Industry
- ZOOZ
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- ZOOZ
- UNCY Health Care
- Exchange
- ZOOZ NYSE
- UNCY Nasdaq
- Market Cap
- ZOOZ 34.7M
- UNCY 31.9M
- IPO Year
- ZOOZ N/A
- UNCY 2021
- Fundamental
- Price
- ZOOZ $2.87
- UNCY $0.66
- Analyst Decision
- ZOOZ Strong Buy
- UNCY Strong Buy
- Analyst Count
- ZOOZ 1
- UNCY 4
- Target Price
- ZOOZ $5.00
- UNCY $5.50
- AVG Volume (30 Days)
- ZOOZ 10.6K
- UNCY 1.4M
- Earning Date
- ZOOZ 12-24-2024
- UNCY 11-13-2024
- Dividend Yield
- ZOOZ N/A
- UNCY N/A
- EPS Growth
- ZOOZ N/A
- UNCY N/A
- EPS
- ZOOZ N/A
- UNCY N/A
- Revenue
- ZOOZ $506,656.00
- UNCY N/A
- Revenue This Year
- ZOOZ N/A
- UNCY N/A
- Revenue Next Year
- ZOOZ $37.50
- UNCY N/A
- P/E Ratio
- ZOOZ N/A
- UNCY N/A
- Revenue Growth
- ZOOZ N/A
- UNCY N/A
- 52 Week Low
- ZOOZ $1.66
- UNCY $0.20
- 52 Week High
- ZOOZ $4.60
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- UNCY 55.55
- Support Level
- ZOOZ N/A
- UNCY $0.62
- Resistance Level
- ZOOZ N/A
- UNCY $0.87
- Average True Range (ATR)
- ZOOZ 0.00
- UNCY 0.07
- MACD
- ZOOZ 0.00
- UNCY -0.01
- Stochastic Oscillator
- ZOOZ 0.00
- UNCY 25.00
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency, and greater flexibility.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.